[Federal Register Volume 83, Number 15 (Tuesday, January 23, 2018)]
[Pages 3172-3173]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01142]



Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.


SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services is hereby giving notice that a 
meeting is scheduled to be held for the National Vaccine Advisory 
Committee (NVAC). The meeting will be open to the public; public 
comment sessions will be held during the meeting.

DATES: The meeting will be held on February 7 and 8, 2018. The meeting 
times and agenda will be posted on the NVAC website at http://www.hhs.gov/nvpo/nvac/meetings/index.html as soon as they become 

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Great Hall, 200 Independence Avenue SW, Washington, 
DC 20201. The meeting can also be accessed through a live webcast on 
both days of the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/index.html.
    Pre-registration is required for members of the public who wish to 
attend the meeting and who wish to participate in the public comment 
session. Individuals who wish to attend the meeting and/or participate 
in the public comment session should register at http://www.hhs.gov/nvpo/nvac/meetings/index.html. Participants may also register by 
emailing [email protected] or by calling (202) 690-5566 and providing their 
name, organization and email address.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW, Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

[[Page 3173]]

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program. During the February 2018 NVAC meeting, sessions will consist 
of presentations on vaccine innovation, including the current status of 
adjuvants in vaccines, universal influenza, and an overview on the 
Secretary of the Department of Health and Human Services' Report to 
Congress on Vaccine Innovation in response to the 21st Century Cures 
Act; a report out on the recently approved Presidential Advisory 
Council on Combatting Antibiotic-Resistant Bacteria Report, 
``Incentivizing the Development of Vaccines, Therapeutics, and 
Diagnostics to Combat Antibiotic Resistant Bacteria''; disparities in 
adult immunizations; and an update on strategies to support improving 
coverage for human papillomavirus vaccine. Please note that agenda 
items will be related to the charge of the Committee and are subject to 
change as priorities dictate. Information on the final meeting agenda 
will be posted prior to the meeting on the NVAC website: http://www.hhs.gov/nvpo/nvac/index.html.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend in person and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the National Vaccine Program Office at 
the address/phone number listed above at least one week prior to the 
meeting. For those unable to attend in person, a live webcast will be 
available. More information on registration and accessing the webcast 
can be found at http://www.hhs.gov/nvpo/nvac/meetings/index.html.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office ([email protected]) at least five 
business days prior to the meeting.

    Dated: January 17, 2018.
Roula Sweis,
Deputy Director, National Vaccine Program Office.
[FR Doc. 2018-01142 Filed 1-22-18; 8:45 am]